Daunorubicin hydrochloride

TargetMol
Product Code: TAR-T1511
Supplier: TargetMol
CodeSizePrice
TAR-T1511-5mg5mg£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1511-10mg10mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1511-1mL1 mL * 10 mM (in DMSO)£116.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1511-25mg25mg£138.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1511-50mg50mg£168.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1511-100mg100mg£229.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1511-200mg200mg£322.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1511-500mg500mg£466.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Daunorubicin hydrochloride, an anthracycline aminoglycoside antineoplastic, inhibits DNA replication and repair and RNA and protein synthesis.
CAS:
23541-50-6
Formula:
C27H30ClNO10
Molecular Weight:
563.98
Pathway:
DNA Damage/DNA Repair; Cell Cycle/Checkpoint; Apoptosis; Autophagy; Microbiology/Virology
Purity:
0.9953
SMILES:
Cl.COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O
Target:
Apoptosis; DNA/RNA Synthesis; Topoisomerase; Antibacterial; Antibiotic; Autophagy

References

1. Gewirtz DA, et al. Biochem Pharmacol, 1999, 57(7), 727-741. 2. Bose R, et al. Cell, 1995, 82(3), 405-414. 3. Fu Y, et al. Thromb Haemost, 2010, 104(6), 1235-1241. 4. Tardi P, et al. Leuk Res, 2009, 33(1), 129-139. 5. Arozal W, et al. Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-? agonist actions. Toxicology. 2011 Jan 11;279(1-3):91-9.